PD-1 blockade in vivo ameliorated macrophage phagocytosis against cancer cells, diminished tumor formation, and prolonged the survival of macrophage-dependent mouse models, which confirmed that PD-1/PD-L1 blockade could interfere with the tumor formation by direct action on macrophages (Gordon et al., 2017). Here, PDCD1 is linked to neoplasm.